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Abstract 
 End-stage renal disease (ESRD) is currently the ninth leading cause of death in the 
United States, and of the 661,00 Americans diagnosed with ESRD, approximately 468,800 were 
on hemodialysis in 2016. Hemodialysis refers to a technique where a machine combined with a 
membrane, often referred to as an artificial kidney, is used to clean blood by removing any waste 
such as urea, potassium, and other smaller waste products while preserving the concentrations 
and integrity of cells and proteins in the blood. It has been shown in artificial blood studies that 
cellulose nanomaterials, like TEMPO/Oxidized cellulose nanoparticles (TOCNs), can be 
integrated into membranes that subsequently display desirable membrane and membrane 
transport properties such as increased flux, urea clearance and fouling resistance. The focus of 
this study was on the application of three variants of these hollow fiber mixed-matrix membranes 
that were derived from two types (partially/fully oxidized) of TOCNs. Hemodialysis was 
performed using hematocrit adjusted bovine blood to analyze a number of transport properties of 
each membrane including protein rejection, blood cell rejection, ionic permeability, and urea 
clearance. The 50/50 mixed-matrix membrane showed promising results with its high ionic 
permeability to divalent cations and improved urea clearance and theoretical treatment time all 
while retaining a comparable concentration of erythrocytes, leukocytes, thrombocytes, and blood 
proteins. Form I and Form II both rejected blood cells and proteins similar to 50/50, however, 
they both had a reduced permeability to divalent cations while also showing little to no 
improvement in urea clearance or treatment time when compared to the control. For these 
reasons, the 50/50 membrane was distinguished as the most viable membrane to base future 
blood hemolysis and membrane characterization studies around due to its exceptional urea 
clearance, reduction of theoretical treatment time, and desirable ionic permeability properties.  
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1. Introduction 
 According to the Center for Disease Control and Prevention, it is estimated that more 
than 1 in 7 US adults currently have chronic kidney disease (CKD)[1]. CKD occurs when an 
individual’s kidneys become damaged and lose their ability to adequately filter their blood. If left 
untreated, CKD has the possibility to progress to further health complications such as kidney 
failure, also known as end-stage renal disease (ESRD), which is currently the ninth leading cause 
of death in the United States [1]. The two main treatments for ESRD are dialysis or a kidney 
transplant, however, according to the National Institute of Diabetes and Digestive and Kidney 
Diseases, of the approximately 661,000 Americans diagnosed with ESRD, 468,000 were on 
dialysis while only 193,000 were living with transplants in 2016 [2]. Kidney transplants have 
been shown to provide an improved quality of life and reduced risk of mortality over dialysis, 
however, the most recent available statistics from the U.S. Department of Health and Human 
Services shows that there were 92,194 Americans on the waitlist for a kidney transplant at the 
end of 2018, and 40% of individuals that were on the waitlist in 2015 were still on the waitlist in 
2018 [3][4].  
 While individuals suffering from ESRD might wait years for a kidney transplant, there is 
a clear need to make improvements upon the current dialysis treatments that are relatively widely 
available when compared to eligible kidney donors that match. One of the main types of dialysis 
that patients with ESRD will undergo is hemodialysis. Hemodialysis refers to a technique where 
a machine combined with a membrane is used to clean blood by removing any waste such as 
urea, potassium, and other smaller waste products. A dialysate solution is used as a washing fluid 
to create an osmotic and chemical gradient for the waste in the blood to make an exchange across 
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the semipermeable membrane by simple diffusion. By changing the ionic concentrations and 
composition of the dialysate, a hemodialysis machine can be finely tuned to select for which ions 
of the blood should be removed or added. The membrane is often referred to as a dialyzer or 
artificial kidney since it is the component of the hemodialysis machine which filters and has 
direct contact with the patient’s blood. The dialyzers are hollow fiber membranes that allow 
blood to pass through the center of the straw-like cylinders while the dialysate solution is 
pumped countercurrent to the direction of the blood flow within the hollow fiber membranes. 
Figure 1 below provides a representation of a simplified hemodialysis machine.  
 
 
Figure 1: A hemodialysis hollow fiber module. [5] 
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 There are a number of high performance dialyzers that are currently on the market which 
are made from synthetic materials such as polysulfone (PSf) or cellulose triacetate (CTA). These 
materials are favored for use in hemodialysis due to their excellent biocompatibility and ability 
to effectively clear target solutes with pore sizes larger than most conventional hemodialysis 
membranes [6]. Since cellulose is the most abundant natural polymer on Earth, it is a very 
appealing material to work with because it is relatively inexpensive and easy to handle. It is also 
well documented that cellulose membranes can be modified to improve their performance during 
hemodialysis thus decreasing the mortality rate when compared to other unmodified membranes 
[7]. Through the use of cellulose nanomaterials (CNM), these existing CTA membranes can be 
further modified to improve a multitude of membrane properties such as membrane strength and 
hydrophilicity, and transport properties which could consequently improve membrane separation 
[8]. Preliminary research on CNM modifications on cellulose membranes, specifically the Form 
I, Form II, and 50/50 hollow fiber Oxone mediated TEMPO-oxidized nano cellulose mixed-
matrix membranes produced by Kristyn Robling in her 2019 thesis, have shown promising 
membrane properties such as increases in flux, mass transfer area coefficient, urea clearance, and 
antifouling properties [9]. TEMPO-cellulose Form I is partially oxidized while TEMPO-
cellulose Form II is fully oxidized. The chemical structure and recently developed production 
method of these two derivatives can be seen in Figure 2 below.  
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Figure 2: The production method from micron cellulose in microwave irradiation conditions  
of Form I and Form II, and the both derivatives chemical structures. [10] 
 
 In collaboration with the University of Arkansas for Medical Sciences, and continuing 
the work done by Kristyn Robling, it is the goal of this research to further characterize the Oxone 
mediated TEMPO-oxidized nano cellulose mixed-matrix membranes through a series of in vitro 
hemodialysis studies using hematocrit adjusted bovine blood. It is hypothesized that the 
derivatives Form I will show an increases in urea clearance and ion permeability, and will 
display comparable biocompatible properties to the control, CTA membranes.  
 
2. Materials and Method 
2.1 Materials 
 Assembled modules each containing 20 fibers of a designated type, CTA, Form I, Form 
II, 50/50, were previously assembled following the procedures outlined in Robling’s 2019 thesis. 
These hollow fiber membranes were created using CTA from Millipore Sigma, N-
methylpyrrolidone (NMP), and deionized water along with pure TEMPO/Oxone-oxidized 
cellulose nanocrystals (TOCNs) and Form I and Form II samples that were prepared by Dr. Peter 
A. Crooks from the University of Arkansas for Medical Sciences. The membranes were 
developed according to the proportions laid out in Table 1 below.  
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Table 1:Composition by weight percentage that the three modified membranes were composed 
according to. [9]  
 
 Hematocrit adjusted bovine blood from Lampire Biological Labs was used as a model for 
human blood throughout the experiments. A fluid pump, dialysate (PBS) solution, warm water 
bath, pressure-rated heparinized dialysis tubing, and beakers to receive the feed out and dialysate 
out were required to begin experimental setup. A 70% ethanol solution would be frequently 
required to sterilize the station, and proper personal protective equipment was necessary as these 
experiments would be with animal blood.  
 
2.2 Hemodialysis 
 To prepare for hemodialysis experiments, the modules were activated through a 
membrane conditioning step. This step is crucial because it essentially primes the membranes for 
the remainder of the experiment by allowing them to adjust to the aqueous pressurized 
environment. The flux of these membranes will vary slightly over time shortly after being 
exposed to a solution. To condition the modules, they were loaded into the apparatus in such a 
way that the eventual dialysate would run countercurrent to the feed bovine blood that would 
travel through the 20 hollow fibers, however, the membranes were initially activated using 25 °C 
deionized water with a consistent transmembrane pressure of 3 psig for one hour. The deionized 
water was passed through the dialysate and feed space both inside and outside of the hollow 
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fibers. Once the membranes reached a more stable state where the pure water flux was changing 
less the 5% per minute, then the blood studies would be initiated. The feed was run at a flow rate 
of 300 mL/min and the dialysate was run at a flow rate of 500 mL/min.  
 While the membranes were being conditioned, the feed bovine blood was warmed in a 
bath to a temperature of 37 °C. When stabilization was reached, the necessary connections were 
switched to facilitate hemodialysis, which involved removing the deionized water feed 
connections and connecting warmed bovine blood to the feed in. The blood was allowed to clean 
run for a few minutes to clear out the residual water that was left in the system. Modules were 
then run in parallel in the interest of time for thirty minutes making sure to collect the used 
dialysate and feed blood. Samples were then taken to be analyzed later. Upon completion of the 
first two modules, these modules were switched out to run the remaining two.  
 When all samples were collected, the hemodialysis was shut down and the module was 
disconnected. A 70% ethanol/water mixture was run through the apparatus without the modules 
attached to disinfect it. All materials were properly sanitized and disposed of in the proper bins.  
 
2.3 Sample Testing 
 The samples collected during hemodialysis were tested using a 96-well plate reading UV-
vis spectrophotometer with a colorimetric assay for urea concentration. For protein analysis, 
samples were sent off to the Central Analytical Laboratory in Poultry Science Center at 
University of Arkansas where serum protein quantity was analyzed by free nitrogen adsorption 
method.  Blood analysis was performed in poultry science on the multi-animal blood analyzer. 
Lastly, salt concentration was analyzed using inductive coupled plasma ISP.  
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3. Results 
3.1 Protein Analysis 
 
Figure 3: Protein concentrations measured for the dialysate solutions that are used for the 
corresponding membrane type. 
 
 Serum protein quantity that was analyzed by free nitrogen adsorption method showed that 
all membranes performed essentially the same with the biggest difference of 0.02% in dialysate 
protein concentration being between the 50/50 and control dialysates. This suggests that all three 
TOCN membranes reject blood proteins at a similar rate as the CTA control.  
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3.2 Ionic Transport Characterization 
 
Figure 4: Varying ion concentrations measured for the dialysate solutions that are used for the 
corresponding membrane type. Ions tested included: (A) Na+, (B) K+, (C) Mg2+, (D) Ca2+. 
 
 All modules performed similarly for allowing the monovalent cations, sodium and 
potassium, to pass through the membranes. However, when it came to the divalent cations, 
magnesium and calcium, the 50/50 membrane seemed to be much more permeable than the 
control, Form I, or Form II. A higher ion permeability would suggest that hemodialysis could be 
more easily controlled by close monitoring of patient blood ion levels and necessary adjustment 
of dialysate solution composition.  
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3.3 Blood Transport Characterization    
Table 2: The blood transport characteristics of cellulose dialysis membranes. 
 
 
 All three mixed-matrix membraned showed the ability to reject erythrocytes, leukocytes, 
and thrombocytes in the blood as efficiently as the control. Platelet counts in the permeates were 
comparable to the control. These results suggest that all tested mixed-matrix membranes have 
pore sizes that are small enough to prevent important blood components, which are retained 
within the kidneys in normal renal filtration, from leaking into the permeate and causing the 
blood to become anemic.  
 
3.4 Urea Transport Characterization 
Table 3: The urea transport characteristics of cellulose dialysis membranes. 
 
 
 The KoA is the mass transfer area coefficient. The mass transfer area coefficient is a 
number that can provide a theoretical clearance value when there is infinite blood and dialysate 
flow rates. A was membrane surface area for each module. Fick’s law (Equation 1 below) was 
Sample
Platelet Rejection 
%
White Blood Cells 
K/uL
Red Blood Cells 
M/uL
Hemoglobin Concentration 
g/dL
Platelets 
K/mL
Initial Blood N/A 10.36 7.33 10.1 447
Form I 0.98 0.02 0 0 7
50/50 0.98 0.02 0 0 11
Form II 0.98 0.02 0 0 7
Control 0.98 0.02 0 0 9
Membrane
Sample
KoA
Experimental 
Clearance 
(mL/min)
Theoretical Clearance for 
1 m2
membrane (mL/min)
Theoretical time to reach 
kt/V of 1.2 (minutes)
Form I 685 7.7 237 213
50/50 1261 11.9 275 183
Form II 888 9.2 255 198
CTA 842 10.1 251 200
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used to calculate the mass transfer area coefficients for each module tested. The solute transport 
rate, N, was calculated using Equation 2. ∆𝑪𝑴 was the log mean concentration difference and 
was calculated using Equation 3 below. The experimental clearance, KExperimental, was calculated 
using Equation 4 below. The mass transfer coefficient and experimental urea clearance values for 
each module tested are in Table 3 above.  
Equation 1: 𝑵 = 𝑲𝒐𝑨𝑨(∆𝑪𝑴) 
Equation 2: 𝑵 =  𝑸𝒇(𝑪𝒇𝒊 − 𝑪𝒇𝒐) = 𝑸𝒅(𝑪𝒅𝒐 − 𝑪𝒅𝒊) 
Equation 3: ∆𝑪𝑴 =
(𝑪𝒇𝒊−𝑪𝒅𝒐)−(𝑪𝒇𝒐−𝑪𝒅𝒊)
𝒍𝒏(
𝑪𝒇𝒊−𝑪𝒅𝒐
𝑪𝒇𝒐−𝑪𝒅𝒊
)
 
Equation 4: 𝑲 =
𝑵
(𝑪𝒇𝒐−𝑪𝒅𝒊)
 
 
 The KExperimental, log mean concentration difference, mass balance, and Fick’s law were 
all used to solve for the theoretical clearance for a membrane with a surface area of 1 m2.  This 
solved equation (Equation 5) can be found below where Qf is equal to the flow of the feed blood 
and Z is the blood flow rate divided by the dialysate flow rate. R is equal to the mass transfer 
coefficient multiplied by the theoretical membrane area, which in this case is 1 m2, divided by 
the flow rate of the dialysate.  
Equation 5: 𝑲 =  𝑸𝒇
𝟏−𝐞𝐱𝐩 (𝑹(𝟏−𝒁))
𝒁−𝐞𝐱𝐩 (𝑹(𝟏−𝒁))
 
The theoretical clearance of a 1 m2 membrane was then used to calculate the theoretical 
treatment time. A model person with a mass of 70 kg and a 60% water weight was used to 
calculate the theoretical treatment time for them to reach a Kt/V of 1.2, which corresponds to the 
Kt/V target set by the US National Kidney Foundation. Results showed that the 50/50 membrane 
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reduced the treatment time by the greatest amount. Form II had a similar treatment time to the 
control while Form I had a higher theoretical treatment time than the control.  
 
4. Conclusion 
After analysis of each membrane, there were improvements found for the 50/50 module 
over the control (CTA) high performance membrane when it came to divalent cation 
permeability and urea clearance while also performing similarly to the control with regards to 
rejection of major erythrocytes, leukocytes, thrombocytes and blood. All three mixed-matrix 
membranes were slightly more permeable to monovalent cations than the control, and all three 
proved to reject proteins and cells in the blood at a comparable level as the CTA control 
membranes. When determining theoretical treatment times, 50/50 was found to have largest mass 
transfer coefficient and the shortest treatment time compared to the control. Although it was 
predicted that the Form I module would perform best during hemodialysis, it appears that the 
50/50 module had the best performance and is a promising candidate for further hemodialysis 
testing of itself and varying derivatives of mixtures of Form I and Form II in the future.  
 
5. Future Work 
 The next step in experiments with these membranes with regards to hemodialysis should 
involve developing new membranes of varying ratios to form a clearer picture of the interaction 
of the two CNMs in the membranes. Given that these CNM mixed-matrix membranes displayed 
biocompatible properties throughout this research and have previously shown low-fouling 
properties, the potential for the eventual development of an implantable artificial kidney device 
should be investigated as current technology progresses.  
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